Publications

Validation of diagnosis codes to identify hospitalized COVID-19 patients in health care claims data.

Pharmacoepidemiol Drug Saf
Kluberg SA, Hou L, Dutcher SK, Billings M, Kit B, Toh S, Dublin S, Haynes K, Kline AM, Maiyani M, Pawloski PA, Watson ES, Cocoros NM

Association of Changes in Obesity Prevalence With the COVID-19 Pandemic in Youth in Massachusetts.

JAMA Pediatr
Wu AJ, Aris IM, Hivert MF, Rocchio C, Cocoros NM, Klompas M, Taveras EM

Impact of an Electronic Medical Record Best Practice Alert on Expedited Partner Therapy for Chlamydia Infection and Reinfection.

Open Forum Infect Dis
Willis SJ, Elder H, Cocoros NM, Callahan M, Hsu KK, Klompas M

Ventilator-Associated Events: Epidemiology, Risk Factors, and Prevention.

Infect Dis Clin North Am
Weinberger J, Cocoros N, Klompas M

Long-term Risk of Parkinson Disease Following Influenza and Other Infections.

JAMA Neurol
Cocoros NM, Svensson E, Szépligeti SK, Vestergaard SV, Szentkúti P, Thomsen RW, Borghammer P, Sørensen HT, Henderson VW

Using inpatient electronic medical records to study influenza for pandemic preparedness.

Influenza Other Respir Viruses
Fuller CC, Cosgrove A, Sands K, Miller KM, Poland RE, Rosen E, Sorbello A, Francis H, Orr R, Dutcher SK, Measer GT, Cocoros NM

Who gets treated for influenza: A surveillance study from the US Food and Drug Administration's Sentinel System.

Infect Control Hosp Epidemiol
Cocoros NM, Haug N, Cosgrove A, Panozzo CA, Sorbello A, Francis H, Garcia C, Orr R, Toh S, Dutcher SK, Measer GT

Validation of an electronic algorithm for Hodgkin and non-Hodgkin Lymphoma in ICD-10-CM.

Pharmacoepidemiol Drug Saf
Epstein MM, Dutcher SK, Maro JC, Saphirak C, DeLuccia S, Ramanathan M, Dhawale T, Harchandani S, Delude C, Hou L, Gertz A, DiNunzio N, McMahill-Walraven CN, Selvan MS, Vigeant J, Cole DV, Leishear K, Gurwitz JH, Andrade S, Cocoros NM

A COVID-19-ready public health surveillance system: The FDA's Sentinel System

Identifying Prescribing Cascades in Alzheimer's Disease and Related Dementias: The Calcium Channel Blocker-Diuretic Prescribing Cascade.

Pharmacoepidemiol Drug Saf
Singh S, Cocoros NM, Haynes K, Nair VP, Harkins TP, Rochon PA, Platt R, Dashevsky I, Reynolds J, Mazor KM, Bloomstone S, Anzuoni K, Crawford SL, Gurwitz JH

Antidopaminergic-Antiparkinsonian Medication Prescribing Cascade in Persons with Alzheimer's Disease.

J Am Geriatr Soc
Singh S, Cocoros NM, Haynes K, Nair VP, Harkins TP, Rochon PA, Platt R, Dashevsky I, Reynolds J, Mazor KM, Bloomstone S, Anzuoni K, Crawford SL, Gurwitz JH

RiskScape: A Data Visualization and Aggregation Platform for Public Health Surveillance Using Routine Electronic Health Record Data.

Am J Public Health
Cocoros NM, Kirby C, Zambarano B, Ochoa A, Eberhardt K, Rocchio Sb C, Ursprung WS, Nielsen VM, Durham NN, Menchaca JT, Josephson M, Erani D, Hafer E, Weiss M, Herrick B, Callahan M, Isaac T, Klompas M

Prescribing cascades in persons with Alzheimer's disease: engaging patients, caregivers, and providers in a qualitative evaluation of print educational materials.

Ther Adv Drug Saf
Bloomstone S, Anzuoni K, Cocoros N, Gurwitz JH, Haynes K, Nair VP, Platt R, Rochon PA, Singh S, Mazor KM

Leveraging the Capabilities of the FDA's Sentinel System To Improve Kidney Care.

J Am Soc Nephrol
Adimadhyam S, Barreto EF, Cocoros NM, Toh S, Brown JS, Maro JC, Corrigan-Curay J, Dal Pan GJ, Ball R, Martin D, Nguyen M, Platt R, Li X

The Certainty Framework for assessing real-world data in studies of medical product safety and effectiveness.

Clin. Pharmacol. Ther.
Cocoros NM, Arlett P, Dreyer NA, Ishiguro C, Iyasu S, Sturkenboom M, Zhou W, Toh S

Can Machine Learning Help Identify Patients at Risk for Recurrent Sexually Transmitted Infections?

Sex Transm Dis
Elder HR, Gruber S, Willis SJ, Cocoros N, Callahan M, Flagg EW, Klompas M, Hsu KK

Risk of Psychiatric Adverse Events among Montelukast Users.

J Allergy Clin Immunol Pract
Sansing-Foster VV, Haug N, Mosholder A, Cocoros NM, Bradley M, Ma Y, Pennap D, Dee EC, Toh S, Pestine E, Petrone AB, Kim I, Lyons JG, Eworuke E

Underuse of oral anticoagulants in privately insured patients with atrial fibrillation: A population being targeted by the IMplementation of a randomized controlled trial to imProve treatment with oral AntiCoagulanTs in patients with Atrial Fibrillation (IMPACT-AFib).

Am. Heart J.
Al-Khatib SM, Pokorney SD, Al-Khalidi HR, Haynes K, Garcia C, Martin D, Goldsack JC, Harkins T, Cocoros NM, Lin ND, Lipowicz H, McCall D, Nair V, Parlett L, McMahill-Walraven CN, Platt R, Granger CB

Diagnosed prevalence of Alzheimer's disease and related dementias in Medicare Advantage plans.

Alzheimers Dement (Amst)
Jutkowitz E, Bynum JPW, Mitchell SL, Cocoros NM, Shapira O, Haynes K, Nair VP, McMahill-Walraven CN, Platt R, McCarthy EP

Practical challenges in the conduct of pragmatic trials embedded in health plans: Lessons of IMPACT-AFib, an FDA-Catalyst trial.

Clin Trials
Garcia CJ, Haynes K, Pokorney SD, Lin ND, McMahill-Walraven C, Nair V, Parlett L, Martin D, Al-Khalidi HR, McCall D, Granger CB, Platt R, Cocoros NM